A cross-sectional study unveiling the global impact and future projections through 2060 of osteoarthritis

一项横断面研究揭示了骨关节炎的全球影响及其到2060年的未来预测

阅读:3

Abstract

Osteoarthritis is a leading degenerative disease worldwide that significantly impairs physical function and quality of life. With an ageing population, the epidemiological burden of osteoarthritis is expected to intensify, making systematic analysis and trend prediction essential for refining treatment and prevention strategies. Data from the 2021 Global Burden of Disease database was employed to analyse trends in the incidence, prevalence, and disability-adjusted life years of osteoarthritis from 1990 to 2021. This research spans global, regional, and national perspectives, aiming to guide future health interventions. By 2021, the number of patients affected by osteoarthritis had reached 607 million, with predictions estimating a rise to 765 million by 2060. There is a positive correlation between Social Development Index and osteoarthritis burden, illustrating that higher incidence and prevalence rates are associated with greater economic development. East Asia currently leads with the highest count of osteoarthritis cases, whereas Oceania has the fewest. Osteoarthritis incidence is climbing across all adult age groups, with women consistently exhibiting higher rates than men at every age. High body mass Index stands as the most significant risk factor for the condition. The total number of osteoarthritis cases is expected to keep rising, underscoring the ongoing challenge in managing this pervasive disease. Osteoarthritis persists as a substantial global health challenge, exhibiting a continuous upward trend from 1990 to 2021. This study provides critical insights for public health policy-making and resource allocation, supporting future interventions and disease control efforts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。